Core Insights - Callan JMB Inc. is expanding its logistics platform into the food sampling industry and has entered agreements to enhance its pharmaceutical logistics capabilities [1][2][3] - The company has established a subsidiary in India to support temperature-controlled pharmaceutical storage and distribution [2][3] - A long-term contract with the City of Chicago has been extended through June 2026, with an increase in funding [2][3] Business Developments - The company has launched operations in the food sampling sector as part of its strategic growth initiatives [2][3] - A preliminary agreement has been made to install oral drug delivery system manufacturing equipment in Texas [2][3] - Callan JMB Services (India) Private Limited has been formed, with plans for a temperature-controlled warehouse in Pune, Maharashtra [2][3] Financial Performance - Revenues for Q3 2025 were $1.4 million, a slight increase from $1.4 million in Q3 2024, while revenues for the nine months ended September 30, 2025, were $4.6 million, down from $5.2 million in the same period last year [8][10] - Gross profit for Q3 2025 was $0.5 million, compared to $0.46 million in Q3 2024, and for the nine months ended September 30, 2025, it was $1.8 million, down from $2.1 million [8][11] - The company reported a net loss of $2.7 million for Q3 2025, compared to a loss of $0.8 million in Q3 2024, and a net loss of $5.4 million for the nine months ended September 30, 2025, compared to a loss of $1.0 million in the same period last year [10][11] Technology Enhancements - The Sentry Monitoring System has been upgraded to version 4.0, allowing for improved temperature monitoring capabilities across devices [2][3]